Can Fatty Liver Give You Diarrhoea?

Can fatty liver give you diarrhoea? While fatty liver disease is not a direct, well-established cause of diarrhoea, digestive disturbance can occur as part of the broader picture of liver dysfunction. The liver plays a central role in bile production, which is essential for fat digestion, and when this is disrupted, bowel habits may be affected. Fatty liver disease also frequently coexists with conditions such as irritable bowel syndrome and type 2 diabetes, which independently alter bowel function. Understanding the link between liver health and digestive symptoms can help you know when to seek medical advice.

Can fatty liver actually cause diarrhoea?

Fatty liver disease is not a direct, established cause of diarrhoea, but impaired bile production and coexisting conditions such as IBS or type 2 diabetes can contribute to looser stools. NICE NG49 does not list diarrhoea as a primary symptom of NAFLD.

Fatty liver disease is not a direct, well-established cause of diarrhoea, but digestive disturbance, including looser stools, can occur as part of the broader picture of liver dysfunction and its associated conditions. Fatty liver disease, known medically as hepatic steatosis, encompasses both non-alcoholic fatty liver disease (NAFLD) and alcohol-related fatty liver disease (ARLD). NHS and NICE guidance (NICE NG49) do not list diarrhoea as a primary symptom of NAFLD or ARLD, and many people with fatty liver have no symptoms at all in the early stages.^[1][2]

The liver plays a central role in digestion, producing bile that is essential for breaking down dietary fats. When liver function is impaired, bile production and flow can be disrupted, which may affect how efficiently fats are absorbed in the gut. It is important to note, however, that pale or greasy stools (steatorrhoea) are more typically associated with significant cholestasis or pancreatic exocrine insufficiency than with uncomplicated NAFLD.^[1][2] If you notice persistently pale or greasy stools, this warrants clinical assessment to exclude these other causes rather than being attributed to fatty liver alone.

Fatty liver disease frequently coexists with other conditions, such as irritable bowel syndrome (IBS), type 2 diabetes, and obesity, all of which independently affect bowel habits. Medications used to manage these associated conditions, including metformin, can also cause diarrhoea as a side effect.^[6][7] It is therefore important not to assume that diarrhoea is caused by fatty liver alone without proper clinical assessment.

If you are experiencing persistent diarrhoea alongside other symptoms that may suggest liver disease, such as fatigue, abdominal discomfort, or jaundice, it is worth discussing this with your GP, who can arrange appropriate investigations.

What digestive symptoms does fatty liver commonly cause?

Fatty liver most commonly causes upper right abdominal discomfort, nausea, bloating, and loss of appetite; diarrhoea is not a defining symptom but changes in bowel frequency can occur. Many people have no symptoms at all in early-stage disease.

Fatty liver disease most commonly causes a dull ache or discomfort in the upper right abdomen, fatigue, and a general sense of feeling unwell, though many people have no symptoms at all in the early stages, as noted in NHS and NICE NG49 guidance. Digestive symptoms, when they do occur, tend to reflect the liver's reduced capacity to support normal digestion rather than direct inflammation of the gut.

Common digestive complaints associated with fatty liver disease include:

• Nausea, particularly after fatty or rich meals

• Bloating and abdominal fullness, which may worsen after eating

• Loss of appetite, especially in more advanced disease

• Pale or greasy stools, more commonly associated with significant cholestasis or pancreatic insufficiency than with simple fatty liver^[1][2]

• Changes in bowel frequency, including both constipation and looser stools

In more advanced liver disease, such as non-alcoholic steatohepatitis (NASH) or cirrhosis, digestive symptoms can become more pronounced. Portal hypertension, a complication of cirrhosis in which pressure builds in the portal vein supplying the liver, is primarily associated with gastrointestinal bleeding (from varices) and fluid accumulation in the abdomen (ascites), as described in NICE NG50. Altered bowel habit may also occur in this context, though it is less specific than bleeding or ascites and should prompt clinical review.

It is also worth noting that the gut microbiome, the community of bacteria living in the intestine, is increasingly recognised in research as playing a role in the development and progression of fatty liver disease. Disruption to the gut microbiome, sometimes called gut dysbiosis, may contribute to both liver inflammation and altered bowel habits, though this remains an area of evolving research and no specific clinical recommendations have yet been issued by NICE or the NHS based on microbiome testing.

Why does liver disease affect your bowel habits?

Liver disease disrupts bile production and flow, reducing efficient fat breakdown and potentially allowing excess bile acids to reach the colon, which can accelerate bowel transit and cause looser stools. The gut-liver axis also links chronic liver inflammation to altered gut permeability.

Liver disease affects bowel habits primarily because the liver is integral to the production and regulation of bile, a digestive fluid that emulsifies dietary fats and supports the absorption of fat-soluble vitamins in the small intestine. When the liver is not functioning optimally, this process is disrupted, and the consequences can be felt throughout the digestive tract.

Bile is produced in the liver, stored in the gallbladder, and released into the small intestine when food is eaten. In fatty liver disease, particularly when inflammation or fibrosis is present, bile composition and flow may be altered. Reduced or abnormal bile secretion means that dietary fats are less efficiently broken down, which can contribute to loose or frequent stools. It is worth noting that significant fat malabsorption leading to steatorrhoea is more characteristic of cholestasis or pancreatic exocrine insufficiency than of uncomplicated fatty liver disease.

The liver also plays a key role in metabolising and excreting substances that pass through the gut. In more advanced liver disease, bile acids that are not adequately processed may reach the colon in greater quantities, where they can stimulate fluid secretion and accelerate bowel transit, contributing to looser stools.^[8][9] This mechanism is distinct from the bile-acid malabsorption seen in ileal disease, and the evidence in the context of fatty liver disease specifically is still developing.

Furthermore, research suggests that the liver is involved in regulating the immune response within the gut. Chronic liver inflammation may be associated with increased gut permeability, sometimes described informally as a "leaky gut", which could allow bacterial products to pass into the bloodstream and perpetuate a cycle of inflammation affecting both the liver and the digestive system. This bidirectional relationship between the gut and the liver, known as the gut-liver axis, is an active area of clinical research. These mechanisms are currently better established in advanced liver disease than in simple fatty liver, and clinical recommendations based on this evidence are not yet available from NICE or the NHS.

When should you see a GP about diarrhoea and liver symptoms?

See a GP if diarrhoea persists for more than four weeks or is accompanied by jaundice, dark urine, pale stools, or unexplained weight loss. Black tarry stools or vomiting blood are emergencies requiring 999 or immediate accident and emergency attendance.

You should see your GP if you have persistent diarrhoea lasting more than four weeks, as this meets the threshold for chronic diarrhoea requiring assessment (per NICE CKS guidance on diarrhoea in adults). This is particularly important if diarrhoea is accompanied by symptoms that may suggest liver disease, such as yellowing of the skin or eyes (jaundice), dark urine, pale stools, unexplained weight loss, or persistent fatigue. These combinations of symptoms warrant prompt clinical assessment and should not be left uninvestigated.

For people with known or suspected NAFLD, NICE NG49 recommends that GPs consider non-invasive fibrosis assessment using a scoring tool such as the FIB-4 or NAFLD Fibrosis Score (NFS) as an initial step. Where the result suggests intermediate or high risk of significant fibrosis, referral for an Enhanced Liver Fibrosis (ELF) test (NICE DG34) or onward referral to hepatology may be appropriate.^[12][13] Liver function tests (LFTs), a full blood count, and an ultrasound scan may also be arranged depending on clinical findings. If fatty liver disease has already been diagnosed, any new or worsening digestive symptoms should be reported to your GP, as they may indicate disease progression or the development of a complication such as cirrhosis.

You should seek more urgent advice in the following situations:

• Diarrhoea containing blood or mucus, which requires prompt assessment

• Black, tarry stools (melaena) or vomiting blood (haematemesis), which are emergencies requiring 999 or immediate attendance at accident and emergency^[14]

• Severe abdominal pain alongside diarrhoea and liver symptoms

• Signs of jaundice that develop suddenly

• Confusion or drowsiness, which in the context of liver disease may suggest hepatic encephalopathy^[4][5]

For urgent advice that does not require an emergency attendance, contact NHS 111. If you are experiencing a life-threatening emergency, such as collapse or severe bleeding, call 999 or go to your nearest accident and emergency department.

For those exploring whether their digestive symptoms may be related to an underlying condition, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support, as one option alongside speaking with your own GP. Suspected side effects from any medicine can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Scientific References

1. Non-alcoholic fatty liver disease (NAFLD).
2. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49).
3. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49) — PDF.
4. Cirrhosis in over 16s: assessment and management (NG50).
5. Cirrhosis in over 16s: assessment and management (NG50) — recommendations chapter.
6. Metformin: a medicine to treat type 2 diabetes.
7. Metformin Tablets — Package Leaflet.
8. The Role of Bile Acids in Chronic Diarrhea.
9. Randomised clinical trial: significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoea.
10. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies.
11. Meta-analysis of the effectiveness of fecal microbiota transplantation in the treatment of metabolic-associated fatty liver disease.
12. MRI-based technologies for assessing non-alcoholic fatty liver disease — The diagnostic tests (HTG655).
13. HTG655 — Final scope: Enhanced Liver Fibrosis (ELF) test in NAFLD.
14. Acute upper gastrointestinal bleeding in over 16s: management (CG141).

Frequently Asked Questions